Literature DB >> 10051981

[Chronic inflammatory bowel disease and pregnancy. Case control study].

I Larzilliere1, P Beau.   

Abstract

OBJECTIVES: To evaluate the influence of inflammatory bowel disease on pregnancy and fetal outcome. PATIENTS AND METHODS: One hundred and fifty pregnancies in 72 women (28 with ulcerative colitis and 44 with Crohn's disease) were compared with those of 150 control subjects.
RESULTS: Among 150 pregnancies, 108 (group I) began before and 42 (group II) at the same time or after the diagnosis of inflammatory bowel disease. In ulcerative colitis patients, age at first pregnancy, mean birth weight and preterm birth rates were not different between groups I and II; rate of underweight offsprings was significantly higher (P < 0.05) in group II than in group I and controls. In Crohn's disease, compared to group I, mean age of first pregnancy was higher (P < 0.0001), mean birth weight was lower (P < 0.005) and preterm birth rate was higher (P = 0.001) than in group II.
CONCLUSION: These results suggest that both ulcerative colitis and Crohn's disease induce deleterious effects on pregnancy and fetal outcome.

Entities:  

Mesh:

Year:  1998        PMID: 10051981

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  11 in total

Review 1.  Inflammatory bowel disease in pregnancy.

Authors:  E M Alstead
Journal:  Postgrad Med J       Date:  2002-01       Impact factor: 2.401

Review 2.  Fertility and pregnancy in inflammatory bowel disease.

Authors:  E Alstead
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

Review 3.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

4.  European evidence based consensus on the diagnosis and management of Crohn's disease: special situations.

Authors:  R Caprilli; M A Gassull; J C Escher; G Moser; P Munkholm; A Forbes; D W Hommes; H Lochs; E Angelucci; A Cocco; B Vucelic; H Hildebrand; S Kolacek; L Riis; M Lukas; R de Franchis; M Hamilton; G Jantschek; P Michetti; C O'Morain; M M Anwar; J L Freitas; I A Mouzas; F Baert; R Mitchell; C J Hawkey
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 5.  Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.

Authors:  Ioannis Androulakis; Christos Zavos; Panagiotis Christopoulos; George Mastorakos; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

6.  Gastrointestinal Conditions during Pregnancy.

Authors:  Sherri A Longo; Robert C Moore; Bernard J Canzoneri; Alfred Robichaux
Journal:  Clin Colon Rectal Surg       Date:  2010-06

Review 7.  Inflammatory Bowel Disease Increases Risk of Adverse Pregnancy Outcomes: A Meta-Analysis.

Authors:  Aoibhlinn O'Toole; Ogochukwu Nwanne; Tracy Tomlinson
Journal:  Dig Dis Sci       Date:  2015-06-13       Impact factor: 3.199

Review 8.  [Pregnancy in patients with rheumatoid arthritis and inflammatory spondylarthropathies].

Authors:  E Gromnica-Ihle; M Ostensen
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

Review 9.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

10.  Inflammatory bowel disease in pregnancy.

Authors:  E M Alstead; C Nelson-Piercy
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.